MONCYTE Health
Develops a personalized diagnostic test to help clinicians select cholesterol-lowering treatments
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-10-28
About MONCYTE Health
MONCYTE Health develops a personalized diagnostic test intended to help clinicians select cholesterol-lowering treatments for patients with high cholesterol. Its technology is designed to support cardiovascular disease treatment and prevention.
The company was founded in 2024 and is headquartered in Helsinki, Finland. It was selected for the AMPlify U.S. market entry program in collaboration with Mayo Clinic and Business Finland.
Product: A personalized diagnostic test designed to guide selection of cholesterol-lowering therapy.
Jobs at MONCYTE Health
No open positions listed right now.
Leadership
- Simon Pfisterer · CSO & founderSource: company website
- Tamara Alagirova · CEO & founderSource: company website
More health & medtech companies
Monday Love
Online wellness coaching and courses for consumers seeking support with nutrition, exercise, weight management and stressNew on EvolcMonidor
Virtual hospital infrastructure that lets hospitals treat patients at home with remote vital-sign monitoringNew on EvolcMoroHoiva
Home nursing and personal assistance for clients in their homes across the Helsinki region, FinlandYoung companyNew on EvolcMovesense
Wearable ECG, heart rate and movement sensors for medical, sports and research customers, sold branded or white-labelledNew on EvolcMukava Biosignals
Gel-free dry electrodes for ECG biosignal monitoring in healthcare and wellness, starting with the MUKAVA C45Young companyNew on EvolcMultivisionDx
AI-powered spatial diagnostics and biomarker analysis for cancer researchers, pathology labs and clinical teamsYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- WooCommerce
- WordPress
- jQuery
- nginx